Antisense-down, but not out
Article Abstract:
The commercial success of the new cholesterol drug, ISIS 301012 launched by Isis Pharmaceuticals with capability to reduce cholesterol by 62%, sent the company's stock to rise by 20 percent.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis
Article Abstract:
The development of new drugs as a result of the genetic sequencing of the Streptomyces avermitilis microorganism is discussed.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
The Streptomyces genome - be prepared!
Article Abstract:
Gene sequencing is expected to assist in drug development. The example of the Streptomyces genome is utilized.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Organizational boundaries and economic performance: an empirical study of entrepreneurial computer firms. The dynamics of the liability of foreignness: a global study of survival in financial services
- Abstracts: Huntington builds the "bricks and mortar" of the information age. Beyond textbook asset-liability management
- Abstracts: The role of economic value, social value, and perceptions of fairness in interorganizational relationship retention decisions
- Abstracts: Is performance driven by industry- or firm-specific factors? A reply to McNamara Aime, and Vaaler. Is performance driven by industry- or firm-specific factors?: a new look at the evidence
- Abstracts: Assessing organizational fitness on a dynamic landscape: an empirical test of the relative inertia thesis. Hospital PR: making the news you want with what you have got